Working… Menu
Trial record 2 of 2 for:    NCT01729754

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis (MODIFY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04339595
Recruitment Status : Recruiting
First Posted : April 9, 2020
Last Update Posted : April 20, 2020
Information provided by (Responsible Party):
Almirall, S.A.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 31, 2022
Estimated Study Completion Date : July 31, 2022